The FDA has notified healthcare professionals and patients that some stolen vials of Levemir (insulin detemir [rDNA origin], from Novo Nordisk), a long-acting insulin, are being sold in the U.S. market. These vials did not circulate through the normal Novo Nordisk distribution channel and, therefore, may not have been stored and handled properly and may be dangerous for patient use. Three lots (129,000 vials) of Levemir insulin 10mL vials were taken in the theft and are identifiable by the following lot numbers: XZF0036, XZF0037, and XZF0038. The FDA is advising patients to check their personal supply and not to use their Levemir insulin if it comes from one of the stolen lots. The lot numbers can be found on the side of the box of insulin or on the side of the vial.

For more information call (800) 727-6500 or visit www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm166358.htm.